Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Oropharyngeal Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Mouth Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Medullary 1

Interventions

Magnetic Resonance Spectroscopy 10 trametinib 7 Nivolumab 7 selpercatinib 6 pembrolizumab 6 dabrafenib 6 Iodine-131 6 Specimen Handling 5 Biopsy 5 lenvatinib 4 Vemurafenib 4 Iodine-124 4 durvalumab 3 cabozantinib 3 binimetinib 3 Ipilimumab 3 Immunoglobulin G 3 Fluorodeoxyglucose F18 3 Disulfides 3 Cyclophosphamide 3 Cetuximab 3 vandetanib 2 ulixertinib 2 omipalisib 2 larotrectinib 2 defactinib 2 copanlisib 2 cemiplimab 2 anlotinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Neck Dissection × 1 year × Clear all

NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡